BIOMAT Database Logo BIOMAT Database Logo

Cardiovascular Risk in Growth Hormone Deficiency: Beneficial Effects of Growth Hormone Replacement Therapy. 2016

Roberto Lanes
Pediatric Endocrine Unit, Hospital de Clinicas Caracas, Avenida Panteon, San Bernardino, Caracas, Venezuela. Electronic address: lanesroberto@gmail.com.

Growth hormone deficiency (GHD) in adulthood is associated with an increased risk of developing adverse cardiovascular events and with reduced life expectancy. Cardiovascular and metabolic abnormalities have so far been evaluated only in a small number of children with GHD and adolescents. In this article we review these abnormalities and their underlying mechanisms and discuss the beneficial effect of growth hormone treatment in subjects with GHD.

UI MeSH Term Description Entries
D008659 Metabolic Diseases Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed) Thesaurismosis,Diseases, Metabolic,Disease, Metabolic,Metabolic Disease,Thesaurismoses
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D019382 Human Growth Hormone A 191-amino acid polypeptide hormone secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR), also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency. Somatotropin (Human),Somatropin (Human),Cryo-Tropin,Genotonorm,Genotropin,Humatrope,Maxomat,Norditropin,Norditropin Simplexx,Norditropine,Nutropin,Omnitrope,Recombinant Human Growth Hormone (Mammalian),Saizen,Serostim,Somatropin,Umatrope,Zomacton,hGH (Human Growth Hormone),r-hGH(m),r-hGH-M,Cryo Tropin,CryoTropin,Growth Hormone, Human
D020249 Hormone Replacement Therapy Therapeutic use of hormones to alleviate the effects of hormone deficiency. Replacement Therapy, Hormone,Therapy, Hormone Replacement,Hormone Replacement Therapies,Replacement Therapies, Hormone,Therapies, Hormone Replacement

Related Publications

Roberto Lanes
Protein metabolism in growth hormone deficiency, and effects of growth hormone replacement therapy.
June 1993, Acta endocrinologica,
Roberto Lanes
[Effects of growth hormone replacement therapy in adults with severe growth hormone deficiency].
October 2000, Orvosi hetilap,
Roberto Lanes
[The beneficial effects of growth hormone replacement therapy on elderly men].
March 1999, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
Roberto Lanes
Cardiovascular risk in patients with growth hormone deficiency: effects of growth hormone substitution.
January 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Roberto Lanes
Consequences of growth hormone deficiency in adults, and effects of growth hormone replacement therapy.
April 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement,
Roberto Lanes
Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults.
May 1994, European journal of endocrinology,
Roberto Lanes
Cardiovascular effects of growth hormone--with special reference to growth hormone replacement therapy.
September 1992, Acta paediatrica (Oslo, Norway : 1992). Supplement,
Roberto Lanes
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile.
April 2022, Pituitary,
Roberto Lanes
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone replacement therapy in adults with growth hormone deficiency.
January 2015, Hormones (Athens, Greece),
Roberto Lanes
Growth hormone deficiency and cardiovascular risk.
July 1998, Bailliere's clinical endocrinology and metabolism,
Copied contents to your clipboard!